Sign In
Buy AMRS
$0.0500
+0 (+0%)
At Close: Nov 27, 2023
Comparing Origin Materials (OTCMKTS:ORGN) & Amyris (NASDAQ:AMRS)
03:40pm, Thursday, 18'th Nov 2021 Dakota Financial News
Origin Materials (OTCMKTS:ORGN) and Amyris (NASDAQ:AMRS) are both oils/energy companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations. Profitability This table compares Origin Materials and Amyris net margins, return on equity and return on assets. []
Tanaka Capital Management Inc Buys Amyris Inc, BeyondSpring Inc, The Carlyle Group Inc, Sells ...
03:38am, Wednesday, 17'th Nov 2021 GuruFocus
Related Stocks: BYSI , NXE , AMRS , CG , MO , CCJ ,
Amyris: Valuations Are Attractive After Hype Around Synthetic Biotech Is Quelled By CEO''s Ambitious Guidance
10:09am, Monday, 15'th Nov 2021 Seeking AlphaAmyris: Valuations Are Attractive After Hype Around Synthetic Biotech Is Quelled By CEO's Ambitious Guidance
05:09am, Monday, 15'th Nov 2021
Amyris' synthetic biotechnology breakthrough with squalene. The real crown jewel of Amyris' current business segment.
Why Shares of Amyris Are Plummeting This Week
07:15pm, Thursday, 11'th Nov 2021
There's nothing artificial about the plunging price of this synthetic biology stock.
Why Shares of Amyris Are Getting Crushed Today
02:50pm, Tuesday, 09'th Nov 2021
Bears are turning their backs on this synbio stock today.
Amyris (AMRS) Stock: Why The Price Substantially Fell Today
01:23pm, Tuesday, 09'th Nov 2021
The stock price of Amyris Inc (NASDAQ: AMRS) fell over 30% during intraday trading today. This is why it happened.
Amyris, Inc. (AMRS) CEO John Melo on Q3 2021 Results - Earnings Call Transcript
10:53pm, Monday, 08'th Nov 2021
Amyris, Inc. (AMRS) CEO John Melo on Q3 2021 Results - Earnings Call Transcript
Amyris, ImmunityBio Join Forces For Next-Gen COVID-19 RNA Vaccine
10:15am, Monday, 08'th Nov 2021
Amyris Inc (NASDAQ: AMRS) has entered into a 50:50 joint venture arrangement with ImmunityBio Inc (NASDAQ: IBRX) to commercialize a next-gen COVID-19 vaccine. The parties have signed a binding te
Amyris: Assessing Financial Capacity To Sustain Organic Growth, Carry COVID Research And Pay For Acquisition
07:33am, Thursday, 04'th Nov 2021
Amyris: Assessing Financial Capacity To Sustain Organic Growth, Carry COVID Research And Pay For Acquisition
3 Genomics Stocks That Could Soar 60% or Better, According to Wall Street
06:17am, Wednesday, 27'th Oct 2021
The genomic revolution is upon us and these stocks could be great vehicles for investors who want to take advantage of it.
3 Great Stocks You Can Buy With $50 Right Now
06:17am, Wednesday, 20'th Oct 2021
You can pick up small pieces of these great businesses for next to nothing.
7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket
12:57pm, Monday, 04'th Oct 2021
Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.
Amyris To Host Fourth Webinar In Its Virtual Investor Mini-Series
08:00am, Wednesday, 22'nd Sep 2021
EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will
Amyris And Jonathan Van Ness Launch JVN Hair A Transformation In Clean Hair Products
08:30am, Thursday, 26'th Aug 2021
EMERYVILLE, Calif., Aug. 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top suppl
